DEVS vs GSK · rev $25.8K vs P/E 13, $103.31B cap
DevvStream Corp. Common Stock (DEVS) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
DevvStream Corp. Common Stock (DEVS) is a pollution & treatment controls company listed on US.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported DEVS revenue for 2025-07-31 was $25.8K. Net income was -$12.1M. DEVS currently screens at market cap $13.4M.
GSK does not have a complete income-statement cache yet.
DEVS currently screens at market cap $13.4M. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the DEVS and GSK stock pages for the full models.
Not investment advice.